TESTOSTERONE
| Brand name | AXIRON |
|---|---|
| Active ingredient | TESTOSTERONE |
| Strength | 30MG/1.5ML ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | SOLUTION, METERED |
| Route | TRANSDERMAL |
| Modality | Small molecule |
| FDA approval | November 2010 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8435944 | September 2027 | use U-1390 |
| 8807861 | February 2027 | product |
| 9289586 | February 2027 | use U-1390 |
| 8419307 | February 2027 | use U-1386 |
| 9180194 | June 2026 | use U-1390 |
| 8993520 | June 2026 | use U-1390 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.